Free Trial

Mitsubishi UFJ Trust & Banking Corp Cuts Stock Position in Molina Healthcare, Inc. (NYSE:MOH)

Molina Healthcare logo with Medical background
Remove Ads

Mitsubishi UFJ Trust & Banking Corp lessened its stake in Molina Healthcare, Inc. (NYSE:MOH - Free Report) by 33.8% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 30,762 shares of the company's stock after selling 15,691 shares during the quarter. Mitsubishi UFJ Trust & Banking Corp owned 0.05% of Molina Healthcare worth $8,953,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors also recently bought and sold shares of the company. True Wealth Design LLC raised its holdings in Molina Healthcare by 2,500.0% in the third quarter. True Wealth Design LLC now owns 104 shares of the company's stock worth $36,000 after buying an additional 100 shares during the last quarter. Versant Capital Management Inc raised its holdings in Molina Healthcare by 83.1% in the 4th quarter. Versant Capital Management Inc now owns 163 shares of the company's stock worth $47,000 after acquiring an additional 74 shares during the last quarter. Wingate Wealth Advisors Inc. purchased a new position in Molina Healthcare in the 4th quarter worth approximately $52,000. EverSource Wealth Advisors LLC lifted its position in Molina Healthcare by 81.5% in the 4th quarter. EverSource Wealth Advisors LLC now owns 196 shares of the company's stock valued at $57,000 after acquiring an additional 88 shares in the last quarter. Finally, Whittier Trust Co. of Nevada Inc. boosted its stake in Molina Healthcare by 337.0% during the 4th quarter. Whittier Trust Co. of Nevada Inc. now owns 201 shares of the company's stock valued at $58,000 after purchasing an additional 155 shares during the last quarter. 98.50% of the stock is owned by hedge funds and other institutional investors.

Remove Ads

Insider Transactions at Molina Healthcare

In other Molina Healthcare news, Director Steven J. Orlando sold 1,000 shares of the company's stock in a transaction on Monday, March 3rd. The stock was sold at an average price of $301.33, for a total transaction of $301,330.00. Following the completion of the sale, the director now owns 17,375 shares in the company, valued at $5,235,608.75. This represents a 5.44 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Corporate insiders own 1.10% of the company's stock.

Analyst Upgrades and Downgrades

A number of equities research analysts have weighed in on MOH shares. Barclays decreased their target price on shares of Molina Healthcare from $372.00 to $339.00 and set an "equal weight" rating for the company in a research note on Friday, February 7th. Wells Fargo & Company upgraded shares of Molina Healthcare from an "equal weight" rating to an "overweight" rating and upped their target price for the company from $295.00 to $372.00 in a research report on Wednesday, March 5th. Stephens reiterated an "equal weight" rating and issued a $345.00 price target on shares of Molina Healthcare in a research report on Thursday, February 6th. Mizuho reduced their price objective on Molina Healthcare from $382.00 to $376.00 and set an "outperform" rating on the stock in a research note on Monday, March 3rd. Finally, UBS Group lowered their price objective on Molina Healthcare from $374.00 to $325.00 and set a "neutral" rating for the company in a research note on Friday, February 7th. Seven research analysts have rated the stock with a hold rating, six have assigned a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat, the stock has an average rating of "Moderate Buy" and an average target price of $348.75.

Read Our Latest Analysis on MOH

Molina Healthcare Trading Up 6.2 %

Shares of NYSE MOH traded up $20.45 during trading hours on Thursday, reaching $348.94. The stock had a trading volume of 167,189 shares, compared to its average volume of 632,948. Molina Healthcare, Inc. has a 52-week low of $262.32 and a 52-week high of $384.35. The firm has a market cap of $19.09 billion, a price-to-earnings ratio of 17.08, a P/E/G ratio of 1.06 and a beta of 0.56. The business's fifty day moving average price is $304.95 and its two-hundred day moving average price is $308.51. The company has a current ratio of 1.62, a quick ratio of 1.62 and a debt-to-equity ratio of 0.69.

Molina Healthcare (NYSE:MOH - Get Free Report) last posted its quarterly earnings results on Wednesday, February 5th. The company reported $5.05 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $5.74 by ($0.69). Molina Healthcare had a return on equity of 28.13% and a net margin of 2.90%. Analysts expect that Molina Healthcare, Inc. will post 24.4 EPS for the current fiscal year.

Molina Healthcare Company Profile

(Free Report)

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.

Featured Articles

Institutional Ownership by Quarter for Molina Healthcare (NYSE:MOH)

Should You Invest $1,000 in Molina Healthcare Right Now?

Before you consider Molina Healthcare, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Molina Healthcare wasn't on the list.

While Molina Healthcare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio?

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Best ETFs for Spring 2025: Strong and Steady Investing

Best ETFs for Spring 2025: Strong and Steady Investing

Whether you're after broad market exposure, dividend income, bonds, or even gold, we've got picks that can help you navigate the current investing landscape.

Related Videos

Massive Buybacks: 3 Stocks Insiders Are Buying Up
Volatility-Proof Your Portfolio with These 7 ETFs

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads